New York, May 22, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Drug-Eluting Stents Industry" - https://www.reportlinker.com/p05443570/?utm_source=GNW
Poised to reach over US$5.3 Billion by the year 2025, Polymer-Free will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 4.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over  US$82.2 Million to the region’s size and clout in the next 5 to 6 years.  Over US$67.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Polymer-Free will reach a market size of US$286.2 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 8.5% over the next couple of years and add approximately US$705.1 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.


Read the full report: https://www.reportlinker.com/p05443570/?utm_source=GNW

DRUG-ELUTING STENTS MCP-1
MARKET ANALYSIS, TRENDS, AND FORECASTS, MAY 2
CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Coronary Stents Market - A Prelude Recent Market Activity Competitive Scenario J&J Exit from DES Market Improves Prospects for Competitors Evolution of the Drug-Eluting Stent Evolution of Drug-Eluting Stents (DES) Over the Years Comparative Analysis of Drug-Eluting Stents in Terms of Physical Parameters Bioabsorbable Stents New Stents with Biodegradable Polymers Completely Bioresorbable Scaffolds: Potential Game-Changer Noteworthy Clinical Studies and Innovations Study Proves Efficacy of Very Thin Strut DES On Par with Durable Polymer Stents Drug-Eluting Stents and Drug-Coated Balloons for Non-Coronary Indications DES for Large Sized Arteries Addressing the Unmet Challenges in Patients with Diabetes Biosensors Commercializes BMX-J DES System SLENDER DES Set to Downsize the Future of Interventional Cardiology Other Novel DES Launches Researchers at University of Strathclyde Evaluate VAN 10-
Small Molecule DES Safe for Vein Grafts Procedures Global Competitor Market Shares Drug-Eluting Stents Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Abbott Laboratories (US) AlviMedica (Turkey) Arterius Limited (UK) B. Braun Melsungen AG (Germany) Biosensors International Group, Ltd. (Singapore) Shandong JW Medical Systems LTD. (China) Biotronik SE & Co. KG (Germany) Boston Scientific Corporation (US) Cook Medical Inc. (US) Elixir Medical Corp. (US) KYOTO MEDICAL PLANNING Co., Ltd. (Japan) Lepu Medical Technology (Beijing) Co., Ltd. (China) Medtronic plc (Republic of Ireland) Micell Technologies, Inc. (US) Opto Circuits (India) Ltd (India) Eurocor GmbH (Germany) OrbusNeich Medical Company Limited (Hong Kong) QualiMed (Germany) Shanghai MicroPort Medical (Group) Co., Ltd. (China) Sino Medical Sciences Technology Inc. (China) STENTYS SA (France) Terumo Corporation (Japan)
3. MARKET TRENDS & DRIVERS
Key Market Drivers & Restraints Aging - A Key Market Driver Global Aging Population Demographic Statistics: Key Opportunity Indicator High Diabetes Incidence Worldwide Drives Demand for Cardiac Surgery and Stents
4. GLOBAL MARKET PERSPECTIVE
Table 1: Drug-Eluting Stents Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 2: Drug-Eluting Stents Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 Table 3: Drug-Eluting Stents Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Polymer-Free (Coating) World Market by Region/Country in US$ Million: 2020 to 2027 Table 5: Polymer-Free (Coating) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 Table 6: Polymer-Free (Coating) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: Polymer-based (Coating) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 Table 8: Polymer-based (Coating) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019 Table 9: Polymer-based (Coating) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 Table 10: Coronary Artery Disease (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027 Table 11: Coronary Artery Disease (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019 Table 12: Coronary Artery Disease (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 Table 13: Peripheral Artery Disease (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027 Table 14: Peripheral Artery Disease (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 Table 15: Peripheral Artery Disease (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 Table 16: Cardiology Centers (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 Table 17: Cardiology Centers (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019 Table 18: Cardiology Centers (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 Table 19: Ambulatory Surgical Centers (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027 Table 20: Ambulatory Surgical Centers (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019 Table 21: Ambulatory Surgical Centers (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 Table 22: Hospitals (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027 Table 23: Hospitals (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019 Table 24: Hospitals (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Drug-Eluting Stents Market Share (in %) by Company: 2018 & 2025 Market Analytics Table 25: United States Drug-Eluting Stents Market Estimates and Projections in US$ Million by Coating: 2020 to 2027 Table 26: Drug-Eluting Stents Market in the United States by Coating: A Historic Review in US$ Million for 2012-2019 Table 27: United States Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 28: United States Drug-Eluting Stents Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 29: Drug-Eluting Stents Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019 Table 30: Drug-Eluting Stents Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027 Table 31: United States Drug-Eluting Stents Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027 Table 32: Drug-Eluting Stents Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019 Table 33: Drug-Eluting Stents Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027 CANADA Table 34: Canadian Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2020 to 2027 Table 35: Canadian Drug-Eluting Stents Historic Market Review by Coating in US$ Million: 2012-2019 Table 36: Drug-Eluting Stents Market in Canada: Percentage Share Breakdown of Sales by Coating for 2012, 2020, and 2027 Table 37: Canadian Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 38: Drug-Eluting Stents Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 39: Canadian Drug-Eluting Stents Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 40: Canadian Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 Table 41: Drug-Eluting Stents Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019 Table 42: Canadian Drug-Eluting Stents Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 JAPAN Table 43: Japanese Market for Drug-Eluting Stents: Annual Sales Estimates and Projections in US$ Million by Coating for the Period 2020-2027 Table 44: Drug-Eluting Stents Market in Japan: Historic Sales Analysis in US$ Million by Coating for the Period 2012-2019 Table 45: Japanese Drug-Eluting Stents Market Share Analysis by Coating: 2012 VS 2020 VS 2027 Table 46: Japanese Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by Application: 2020 to 2027 Table 47: Japanese Drug-Eluting Stents Market in US$ Million by Application: 2012-2019 Table 48: Drug-Eluting Stents Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027 Table 49: Japanese Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by End-Use: 2020 to 2027 Table 50: Japanese Drug-Eluting Stents Market in US$ Million by End-Use: 2012-2019 Table 51: Drug-Eluting Stents Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027 CHINA Table 52: Chinese Drug-Eluting Stents Market Growth Prospects in US$ Million by Coating for the Period 2020-2027 Table 53: Drug-Eluting Stents Historic Market Analysis in China in US$ Million by Coating: 2012-2019 Table 54: Chinese Drug-Eluting Stents Market by Coating: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 55: Chinese Demand for Drug-Eluting Stents in US$ Million by Application: 2020 to 2027 Table 56: Drug-Eluting Stents Market Review in China in US$ Million by Application: 2012-2019 Table 57: Chinese Drug-Eluting Stents Market Share Breakdown by Application: 2012 VS 2020 VS 2027 Table 58: Chinese Demand for Drug-Eluting Stents in US$ Million by End-Use: 2020 to 2027 Table 59: Drug-Eluting Stents Market Review in China in US$ Million by End-Use: 2012-2019 Table 60: Chinese Drug-Eluting Stents Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 EUROPE Market Facts & Figures European Drug-Eluting Stents Market: Competitor Market Share Scenario (in %) for 2018 & 2025 Market Analytics Table 61: European Drug-Eluting Stents Market Demand Scenario in US$ Million by Region/Country: 2020-2027 Table 62: Drug-Eluting Stents Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019 Table 63: European Drug-Eluting Stents Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 Table 64: European Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2020-2027 Table 65: Drug-Eluting Stents Market in Europe in US$ Million by Coating: A Historic Review for the Period 2012-2019 Table 66: European Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 67: European Drug-Eluting Stents Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 68: Drug-Eluting Stents Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 69: European Drug-Eluting Stents Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 70: European Drug-Eluting Stents Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 Table 71: Drug-Eluting Stents Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019 Table 72: European Drug-Eluting Stents Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 FRANCE Table 73: Drug-Eluting Stents Market in France by Coating: Estimates and Projections in US$ Million for the Period 2020-2027 Table 74: French Drug-Eluting Stents Historic Market Scenario in US$ Million by Coating: 2012-2019 Table 75: French Drug-Eluting Stents Market Share Analysis by Coating: 2012 VS 2020 VS 2027 Table 76: Drug-Eluting Stents Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027 Table 77: French Drug-Eluting Stents Historic Market Review in US$ Million by Application: 2012-2019 Table 78: French Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 Table 79: Drug-Eluting Stents Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027 Table 80: French Drug-Eluting Stents Historic Market Review in US$ Million by End-Use: 2012-2019 Table 81: French Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 GERMANY Table 82: Drug-Eluting Stents Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2020-2027 Table 83: German Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2012-2019 Table 84: German Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 85: Drug-Eluting Stents Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 86: German Drug-Eluting Stents Market in Retrospect in US$ Million by Application: 2012-2019 Table 87: Drug-Eluting Stents Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027 Table 88: Drug-Eluting Stents Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027 Table 89: German Drug-Eluting Stents Market in Retrospect in US$ Million by End-Use: 2012-2019 Table 90: Drug-Eluting Stents Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027 ITALY Table 91: Italian Drug-Eluting Stents Market Growth Prospects in US$ Million by Coating for the Period 2020-2027 Table 92: Drug-Eluting Stents Historic Market Analysis in Italy in US$ Million by Coating: 2012-2019 Table 93: Italian Drug-Eluting Stents Market by Coating: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 94: Italian Demand for Drug-Eluting Stents in US$ Million by Application: 2020 to 2027 Table 95: Drug-Eluting Stents Market Review in Italy in US$ Million by Application: 2012-2019 Table 96: Italian Drug-Eluting Stents Market Share Breakdown by Application: 2012 VS 2020 VS 2027 Table 97: Italian Demand for Drug-Eluting Stents in US$ Million by End-Use: 2020 to 2027 Table 98: Drug-Eluting Stents Market Review in Italy in US$ Million by End-Use: 2012-2019 Table 99: Italian Drug-Eluting Stents Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 UNITED KINGDOM Table 100: United Kingdom Market for Drug-Eluting Stents: Annual Sales Estimates and Projections in US$ Million by Coating for the Period 2020-2027 Table 101: Drug-Eluting Stents Market in the United Kingdom: Historic Sales Analysis in US$ Million by Coating for the Period 2012-2019 Table 102: United Kingdom Drug-Eluting Stents Market Share Analysis by Coating: 2012 VS 2020 VS 2027 Table 103: United Kingdom Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by Application: 2020 to 2027 Table 104: United Kingdom Drug-Eluting Stents Market in US$ Million by Application: 2012-2019 Table 105: Drug-Eluting Stents Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027 Table 106: United Kingdom Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by End-Use: 2020 to 2027 Table 107: United Kingdom Drug-Eluting Stents Market in US$ Million by End-Use: 2012-2019 Table 108: Drug-Eluting Stents Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027 SPAIN Table 109: Spanish Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2020 to 2027 Table 110: Spanish Drug-Eluting Stents Historic Market Review by Coating in US$ Million: 2012-2019 Table 111: Drug-Eluting Stents Market in Spain: Percentage Share Breakdown of Sales by Coating for 2012, 2020, and 2027 Table 112: Spanish Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 113: Drug-Eluting Stents Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 114: Spanish Drug-Eluting Stents Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 115: Spanish Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 Table 116: Drug-Eluting Stents Market in Spain: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019 Table 117: Spanish Drug-Eluting Stents Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 RUSSIA Table 118: Russian Drug-Eluting Stents Market Estimates and Projections in US$ Million by Coating: 2020 to 2027 Table 119: Drug-Eluting Stents Market in Russia by Coating: A Historic Review in US$ Million for 2012-2019 Table 120: Russian Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 121: Russian Drug-Eluting Stents Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 122: Drug-Eluting Stents Historic Demand Patterns in Russia by Application in US$ Million for 2012-2019 Table 123: Drug-Eluting Stents Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027 Table 124: Russian Drug-Eluting Stents Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027 Table 125: Drug-Eluting Stents Historic Demand Patterns in Russia by End-Use in US$ Million for 2012-2019 Table 126: Drug-Eluting Stents Market Share Breakdown in Russia by End-Use: 2012 VS 2020 VS 2027 REST OF EUROPE Table 127: Rest of Europe Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2020-2027 Table 128: Drug-Eluting Stents Market in Rest of Europe in US$ Million by Coating: A Historic Review for the Period 2012-2019 Table 129: Rest of Europe Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 130: Rest of Europe Drug-Eluting Stents Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 131: Drug-Eluting Stents Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 132: Rest of Europe Drug-Eluting Stents Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 133: Rest of Europe Drug-Eluting Stents Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 Table 134: Drug-Eluting Stents Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019 Table 135: Rest of Europe Drug-Eluting Stents Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 ASIA-PACIFIC Table 136: Asia-Pacific Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 137: Drug-Eluting Stents Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019 Table 138: Asia-Pacific Drug-Eluting Stents Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 Table 139: Drug-Eluting Stents Market in Asia-Pacific by Coating: Estimates and Projections in US$ Million for the Period 2020-2027 Table 140: Asia-Pacific Drug-Eluting Stents Historic Market Scenario in US$ Million by Coating: 2012-2019 Table 141: Asia-Pacific Drug-Eluting Stents Market Share Analysis by Coating: 2012 VS 2020 VS 2027 Table 142: Drug-Eluting Stents Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027 Table 143: Asia-Pacific Drug-Eluting Stents Historic Market Review in US$ Million by Application: 2012-2019 Table 144: Asia-Pacific Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 Table 145: Drug-Eluting Stents Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027 Table 146: Asia-Pacific Drug-Eluting Stents Historic Market Review in US$ Million by End-Use: 2012-2019 Table 147: Asia-Pacific Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 AUSTRALIA Table 148: Drug-Eluting Stents Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2020-2027 Table 149: Australian Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2012-2019 Table 150: Australian Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 151: Drug-Eluting Stents Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 152: Australian Drug-Eluting Stents Market in Retrospect in US$ Million by Application: 2012-2019 Table 153: Drug-Eluting Stents Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027 Table 154: Drug-Eluting Stents Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027 Table 155: Australian Drug-Eluting Stents Market in Retrospect in US$ Million by End-Use: 2012-2019 Table 156: Drug-Eluting Stents Market Share Distribution in Australia by End-Use: 2012 VS 2020 VS 2027 INDIA Table 157: Indian Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2020 to 2027 Table 158: Indian Drug-Eluting Stents Historic Market Review by Coating in US$ Million: 2012-2019 Table 159: Drug-Eluting Stents Market in India: Percentage Share Breakdown of Sales by Coating for 2012, 2020, and 2027 Table 160: Indian Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 161: Drug-Eluting Stents Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 162: Indian Drug-Eluting Stents Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 163: Indian Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 Table 164: Drug-Eluting Stents Market in India: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019 Table 165: Indian Drug-Eluting Stents Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 SOUTH KOREA Table 166: Drug-Eluting Stents Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2020-2027 Table 167: South Korean Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2012-2019 Table 168: Drug-Eluting Stents Market Share Distribution in South Korea by Coating: 2012 VS 2020 VS 2027 Table 169: Drug-Eluting Stents Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027 Table 170: South Korean Drug-Eluting Stents Historic Market Analysis in US$ Million by Application: 2012-2019 Table 171: Drug-Eluting Stents Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027 Table 172: Drug-Eluting Stents Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027 Table 173: South Korean Drug-Eluting Stents Historic Market Analysis in US$ Million by End-Use: 2012-2019 Table 174: Drug-Eluting Stents Market Share Distribution in South Korea by End-Use: 2012 VS 2020 VS 2027 REST OF ASIA-PACIFIC Table 175: Rest of Asia-Pacific Market for Drug-Eluting Stents: Annual Sales Estimates and Projections in US$ Million by Coating for the Period 2020-2027 Table 176: Drug-Eluting Stents Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Coating for the Period 2012-2019 Table 177: Rest of Asia-Pacific Drug-Eluting Stents Market Share Analysis by Coating: 2012 VS 2020 VS 2027 Table 178: Rest of Asia-Pacific Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by Application: 2020 to 2027 Table 179: Rest of Asia-Pacific Drug-Eluting Stents Market in US$ Million by Application: 2012-2019 Table 180: Drug-Eluting Stents Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027 Table 181: Rest of Asia-Pacific Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by End-Use: 2020 to 2027 Table 182: Rest of Asia-Pacific Drug-Eluting Stents Market in US$ Million by End-Use: 2012-2019 Table 183: Drug-Eluting Stents Market Share Shift in Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027 LATIN AMERICA Table 184: Latin American Drug-Eluting Stents Market Trends by Region/Country in US$ Million: 2020-2027 Table 185: Drug-Eluting Stents Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019 Table 186: Latin American Drug-Eluting Stents Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 Table 187: Latin American Drug-Eluting Stents Market Growth Prospects in US$ Million by Coating for the Period 2020-2027 Table 188: Drug-Eluting Stents Historic Market Analysis in Latin America in US$ Million by Coating: 2012-2019 Table 189: Latin American Drug-Eluting Stents Market by Coating: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 190: Latin American Demand for Drug-Eluting Stents in US$ Million by Application: 2020 to 2027 Table 191: Drug-Eluting Stents Market Review in Latin America in US$ Million by Application: 2012-2019 Table 192: Latin American Drug-Eluting Stents Market Share Breakdown by Application: 2012 VS 2020 VS 2027 Table 193: Latin American Demand for Drug-Eluting Stents in US$ Million by End-Use: 2020 to 2027 Table 194: Drug-Eluting Stents Market Review in Latin America in US$ Million by End-Use: 2012-2019 Table 195: Latin American Drug-Eluting Stents Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 ARGENTINA Table 196: Argentinean Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2020-2027 Table 197: Drug-Eluting Stents Market in Argentina in US$ Million by Coating: A Historic Review for the Period 2012-2019 Table 198: Argentinean Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 199: Argentinean Drug-Eluting Stents Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 200: Drug-Eluting Stents Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 201: Argentinean Drug-Eluting Stents Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 202: Argentinean Drug-Eluting Stents Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 Table 203: Drug-Eluting Stents Market in Argentina: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019 Table 204: Argentinean Drug-Eluting Stents Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 BRAZIL Table 205: Drug-Eluting Stents Market in Brazil by Coating: Estimates and Projections in US$ Million for the Period 2020-2027 Table 206: Brazilian Drug-Eluting Stents Historic Market Scenario in US$ Million by Coating: 2012-2019 Table 207: Brazilian Drug-Eluting Stents Market Share Analysis by Coating: 2012 VS 2020 VS 2027 Table 208: Drug-Eluting Stents Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020-2027 Table 209: Brazilian Drug-Eluting Stents Historic Market Review in US$ Million by Application: 2012-2019 Table 210: Brazilian Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027 Table 211: Drug-Eluting Stents Quantitative Demand Analysis in Brazil in US$ Million by End-Use: 2020-2027 Table 212: Brazilian Drug-Eluting Stents Historic Market Review in US$ Million by End-Use: 2012-2019 Table 213: Brazilian Drug-Eluting Stents Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 MEXICO Table 214: Drug-Eluting Stents Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2020-2027 Table 215: Mexican Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2012-2019 Table 216: Mexican Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 217: Drug-Eluting Stents Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 218: Mexican Drug-Eluting Stents Market in Retrospect in US$ Million by Application: 2012-2019 Table 219: Drug-Eluting Stents Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027 Table 220: Drug-Eluting Stents Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027 Table 221: Mexican Drug-Eluting Stents Market in Retrospect in US$ Million by End-Use: 2012-2019 Table 222: Drug-Eluting Stents Market Share Distribution in Mexico by End-Use: 2012 VS 2020 VS 2027 REST OF LATIN AMERICA Table 223: Rest of Latin America Drug-Eluting Stents Market Estimates and Projections in US$ Million by Coating: 2020 to 2027 Table 224: Drug-Eluting Stents Market in Rest of Latin America by Coating: A Historic Review in US$ Million for 2012-2019 Table 225: Rest of Latin America Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 226: Rest of Latin America Drug-Eluting Stents Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 227: Drug-Eluting Stents Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012-2019 Table 228: Drug-Eluting Stents Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027 Table 229: Rest of Latin America Drug-Eluting Stents Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027 Table 230: Drug-Eluting Stents Historic Demand Patterns in Rest of Latin America by End-Use in US$ Million for 2012-2019 Table 231: Drug-Eluting Stents Market Share Breakdown in Rest of Latin America by End-Use: 2012 VS 2020 VS 2027 MIDDLE EAST Table 232: The Middle East Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 Table 233: Drug-Eluting Stents Market in the Middle East by Region/Country in US$ Million: 2012-2019 Table 234: The Middle East Drug-Eluting Stents Market Share Breakdown by Region/Country: 2012, 2020, and 2027 Table 235: The Middle East Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2020 to 2027 Table 236: The Middle East Drug-Eluting Stents Historic Market by Coating in US$ Million: 2012-2019 Table 237: Drug-Eluting Stents Market in the Middle East: Percentage Share Breakdown of Sales by Coating for 2012,2020, and 2027 Table 238: The Middle East Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027 Table 239: Drug-Eluting Stents Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019 Table 240: The Middle East Drug-Eluting Stents Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 241: The Middle East Drug-Eluting Stents Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 Table 242: Drug-Eluting Stents Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019 Table 243: The Middle East Drug-Eluting Stents Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 IRAN Table 244: Iranian Market for Drug-Eluting Stents: Annual Sales Estimates and Projections in US$ Million by Coating for the Period 2020-2027 Table 245: Drug-Eluting Stents Market in Iran: Historic Sales Analysis in US$ Million by Coating for the Period 2012-2019 Table 246: Iranian Drug-Eluting Stents Market Share Analysis by Coating: 2012 VS 2020 VS 2027 Table 247: Iranian Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by Application: 2020 to 2027 Table 248: Iranian Drug-Eluting Stents Market in US$ Million by Application: 2012-2019 Table 249: Drug-Eluting Stents Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027 Table 250: Iranian Demand Estimates and Forecasts for Drug-Eluting Stents in US$ Million by End-Use: 2020 to 2027 Table 251: Iranian Drug-Eluting Stents Market in US$ Million by End-Use: 2012-2019 Table 252: Drug-Eluting Stents Market Share Shift in Iran by End-Use: 2012 VS 2020 VS 2027 ISRAEL Table 253: Israeli Drug-Eluting Stents Market Estimates and Forecasts in US$ Million by Coating: 2020-2027 Table 254: Drug-Eluting Stents Market in Israel in US$ Million by Coating: A Historic Review for the Period 2012-2019 Table 255: Israeli Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 256: Israeli Drug-Eluting Stents Addressable Market Opportunity in US$ Million by Application: 2020-2027 Table 257: Drug-Eluting Stents Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019 Table 258: Israeli Drug-Eluting Stents Market Share Analysis by Application: 2012 VS 2020 VS 2027 Table 259: Israeli Drug-Eluting Stents Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 Table 260: Drug-Eluting Stents Market in Israel: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019 Table 261: Israeli Drug-Eluting Stents Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 SAUDI ARABIA Table 262: Saudi Arabian Drug-Eluting Stents Market Growth Prospects in US$ Million by Coating for the Period 2020-2027 Table 263: Drug-Eluting Stents Historic Market Analysis in Saudi Arabia in US$ Million by Coating: 2012-2019 Table 264: Saudi Arabian Drug-Eluting Stents Market by Coating: Percentage Breakdown of Sales for 2012, 2020, and 2027 Table 265: Saudi Arabian Demand for Drug-Eluting Stents in US$ Million by Application: 2020 to 2027 Table 266: Drug-Eluting Stents Market Review in Saudi Arabia in US$ Million by Application: 2012-2019 Table 267: Saudi Arabian Drug-Eluting Stents Market Share Breakdown by Application: 2012 VS 2020 VS 2027 Table 268: Saudi Arabian Demand for Drug-Eluting Stents in US$ Million by End-Use: 2020 to 2027 Table 269: Drug-Eluting Stents Market Review in Saudi Arabia in US$ Million by End-Use: 2012-2019 Table 270: Saudi Arabian Drug-Eluting Stents Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 UNITED ARAB EMIRATES Table 271: Drug-Eluting Stents Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2020-2027 Table 272: United Arab Emirates Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2012-2019 Table 273: Drug-Eluting Stents Market Share Distribution in United Arab Emirates by Coating: 2012 VS 2020 VS 2027 Table 274: Drug-Eluting Stents Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027 Table 275: United Arab Emirates Drug-Eluting Stents Historic Market Analysis in US$ Million by Application: 2012-2019 Table 276: Drug-Eluting Stents Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027 Table 277: Drug-Eluting Stents Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027 Table 278: United Arab Emirates Drug-Eluting Stents Historic Market Analysis in US$ Million by End-Use: 2012-2019 Table 279: Drug-Eluting Stents Market Share Distribution in United Arab Emirates by End-Use: 2012 VS 2020 VS 2027 REST OF MIDDLE EAST Table 280: Drug-Eluting Stents Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Coating for the Period 2020-2027 Table 281: Rest of Middle East Drug-Eluting Stents Historic Market Analysis in US$ Million by Coating: 2012-2019 Table 282: Rest of Middle East Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 283: Drug-Eluting Stents Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027 Table 284: Rest of Middle East Drug-Eluting Stents Market in Retrospect in US$ Million by Application: 2012-2019 Table 285: Drug-Eluting Stents Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027 Table 286: Drug-Eluting Stents Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027 Table 287: Rest of Middle East Drug-Eluting Stents Market in Retrospect in US$ Million by End-Use: 2012-2019 Table 288: Drug-Eluting Stents Market Share Distribution in Rest of Middle East by End-Use: 2012 VS 2020 VS 2027 AFRICA Table 289: African Drug-Eluting Stents Market Estimates and Projections in US$ Million by Coating: 2020 to 2027 Table 290: Drug-Eluting Stents Market in Africa by Coating: A Historic Review in US$ Million for 2012-2019 Table 291: African Drug-Eluting Stents Market Share Breakdown by Coating: 2012 VS 2020 VS 2027 Table 292: African Drug-Eluting Stents Latent Demand Forecasts in US$ Million by Application: 2020 to 2027 Table 293: Drug-Eluting Stents Historic Demand Patterns in Africa by Application in US$ Million for 2012-2019 Table 294: Drug-Eluting Stents Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027 Table 295: African Drug-Eluting Stents Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027 Table 296: Drug-Eluting Stents Historic Demand Patterns in Africa by End-Use in US$ Million for 2012-2019 Table 297: Drug-Eluting Stents Market Share Breakdown in Africa by End-Use: 2012 VS 2020 VS 2027
IV. COMPETITION

Total Companies Profiled: 35
Read the full report: https://www.reportlinker.com/p05443570/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001